NASDAQ: EYENational Vision Holdings Inc Stock
$11.00-0.67 (-5.74%)
Updated Apr 21, 2025
EYE Price
$11.00
Fair Value Price
$13.30
Market Cap
$866.62M
52 Week Low
$9.56
52 Week High
$18.99
P/E
-30.56x
P/B
1.06x
P/S
0.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.82B
Earnings
-$28.50M
Gross Margin
58.1%
Operating Margin
-0.59%
Profit Margin
-1.6%
Debt to Equity
1.46
Operating Cash Flow
$134M
Beta
1.26
Next Earnings
May 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
EYE Overview
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 1, 2022, the company operated through 1,278 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EYE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Retail
Industry Rating
D
EYE
Ranked#22 of 39
Ranked#22 of 39
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.95 | B | |
| $137.87 | B | |
| $33.46 | C |
Be the first to know about important EYE news, forecast changes, insider trades & much more!
EYE News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EYE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EYE ($11.00) is undervalued by 17.3% relative to our estimate of its Fair Value price of $13.30 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
EYE ($11.00) is not significantly undervalued (17.3%) relative to our estimate of its Fair Value price of $13.30 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
EYE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EYE due diligence checks available for Premium users.
Valuation
EYE fair value
Fair Value of EYE stock based on Discounted Cash Flow (DCF)
Price
$11.00
Fair Value
$13.30
Undervalued by
17.30%
EYE ($11.00) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EYE ($11.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EYE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
EYE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-30.56x
Industry
25.07x
Market
27.14x
EYE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.06x
Industry
9.24x
EYE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EYE's financial health
Profit margin
Revenue
$437.3M
Net Income
-$28.6M
Profit Margin
-6.5%
EYE's Earnings (EBIT) of -$10.83M... subscribe to Premium to read more.
Interest Coverage Financials
EYE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.0B
Liabilities
$1.2B
Debt to equity
1.46
EYE's short-term liabilities ($468.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EYE's long-term liabilities ($723.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EYE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EYE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$30.3M
Investing
-$33.7M
Financing
-$4.0M
EYE's operating cash flow ($133.65M)... subscribe to Premium to read more.
Debt Coverage Financials
EYE vs Retail Stocks
National Vision Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.